China in supply chains

- Business Insider reports Tim Cook made China central to Apple’s growth strategy across manufacturing and sales. (businessinsider.com) - Asia Times separately warns the U.S. pharmaceutical supply chain still depends heavily on China for drugs and ingredients. (asiatimes.com) - Deep reliance on China for tech and medicine helps explain why trade policy and diplomatic tensions quickly affect prices and availability. (businessinsider.com) (asiatimes.com)

China sits at the center of two supply chains Americans notice fastest: iPhones and prescription drugs. (businessinsider.com) (asiatimes.com) Business Insider reported on April 21 that Tim Cook made China core to Apple’s model, both as a factory base and as a major sales market during his 15 years as chief executive. Apple said on January 29 that its fiscal first-quarter 2026 revenue reached $143.8 billion, up 16% year over year. (businessinsider.com) (apple.com) CNBC reported on March 20 that iPhone sales in China jumped 23% at the start of 2026 even as China’s broader smartphone market fell 4%. Tim Cook visited Chengdu that week for Apple’s 50th-anniversary events as Beijing remained one of Apple’s biggest markets. (cnbc.com) Drug supply chains work in layers: chemical ingredients are made first, then turned into finished pills, injections, or capsules. The Food and Drug Administration says manufacturers must report some interruptions in both finished products and active pharmaceutical ingredients, the key drug compounds that do the medical work. (fda.gov) (uspharmacist.com) Asia Times reported in April that the United States still relies heavily on China for drug ingredients and upstream chemical inputs. The Council on Foreign Relations has previously cited estimates that about 80% of active pharmaceutical ingredients used in U.S. drugs come from China and other countries such as India, with exact dependence hard to pin down. (asiatimes.com) (cfr.org) That dependence shows up when supply breaks. The Food and Drug Administration says manufacturers should first check its public shortages database by generic name or active ingredient, and the agency says it is actively working to resolve listed shortages. (fda.gov 1) (fda.gov 2) Trade policy now lands directly on consumer goods and medical inputs because the United States and China remain deeply tied in both sectors. The Council on Foreign Relations said on April 16 that full economic decoupling between the world’s two largest economies is likely impossible even as trade tensions keep rising. (cfr.org) The same pattern has frustrated Washington for years. A Council on Foreign Relations analysis said a 2024 Department of Defense review found 54% of that department’s pharmaceutical supply chain depended on China, India, or unknown sources. (cfr.org) Apple has started shifting some production outside China, but the China link remains hard to unwind because manufacturing scale, supplier networks, and local demand are all concentrated there. In medicine, the Food and Drug Administration says it can help mitigate shortages but cannot force a company to make more of a drug or move production. (axios.com) (fda.gov) That is why a tariff announcement, an export control, or a diplomatic clash can move from policy to store shelves and pharmacy counters in days. The structure of the supply chain, not just the politics around it, keeps China central to what Americans can buy and how much they pay. (businessinsider.com) (asiatimes.com)

Get your own daily briefing

Scout delivers personalized news, insights, and conversations tailored to your role and industry.

Download on the App Store

Shared from Scout - Be the smartest in the room.